Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Personalized treatment for persistent vertigo caused by BPPV

Official title: Personalized Medicine to Treat Refractory Benign Paroxysmal Positional Vertigo, Through Computational Fluid Dynamics Analysis From Magnetic Resonance Image Reconstructions

Run by Hospital Clinico Universitario de Santiago · NCT06725966 · Data updated 2026-11-12

This study is testing if personalized treatments for vertigo, based on each person's unique inner ear structure, can help people who haven't found relief from standard methods for BPPV.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment54 (estimated)
SponsorHospital Clinico Universitario de Santiago
Academic / other
Locations1 site (Santiago de Compostela, A Coruña)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 10, 2024
Trial IDNCT06725966 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old diagnosed with unilateral refractory posterior canal BPPV.

Probably not a fit

Patients with cognitive impairments or those with BPPV involving canals other than the posterior canal may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients suffering from refractory benign paroxysmal positional vertigo (BPPV), a common cause of vertigo that does not respond to standard treatments. It employs a personalized medicine approach using computational fluid dynamics (CFD) based on MRI scans to tailor canalith repositioning maneuvers (CRMs) to individual anatomical variations in the inner ear. Participants will be randomly assigned to receive either standard CRMs or personalized CRMs designed from their unique inner ear anatomy. The study aims to improve treatment outcomes for patients who have not found relief from conventional methods.

Why it matters

Potential benefit: If successful, this approach could significantly reduce persistent vertigo symptoms in patients with refractory BPPV.

How similar studies have gone: While personalized approaches in treating BPPV are relatively novel, similar studies in other conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A. Diagnosed with BPPVp according to the Barany Society criteria:

  1. Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.
  2. Episodes lasting less than 1 minute.
  3. Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right).
  4. Symptoms not explained by any other cause.

     AND
* B. Refractory to otolith repositioning maneuvers (Epley and/or Semont maneuvers), with persistence of symptoms after three attempts.

Exclusion Criteria:

* Cognitive impairment that prevents understanding of their condition and the required procedures.
* Pathological conditions that hinder the execution of the maneuvers.
* BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.
* Low educational level, which may impede understanding of the procedures and informed consent.

Where it's running

  • Hospital Clínico Universitario
    Santiago de Compostela, A Coruña, Spain
    Recruiting

Study contacts

  • Principal investigator: Andrés Soto-Varela, Prof, PhD — Complexo Hospitalario Universitario de Santiago
  • Study coordinator: Andrés Soto-Varela, Prof, PhD
  • Email: andres.soto.varela@sergas.es
  • Phone: +34981951157

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.